As the production and distribution of SARS-CoV-2 vaccines ramps up in the United States, there is a need to ensure that communities at highest risk for severe COVID-19 morbidity and mortality are targeted. As of February 2021, the Pfizer/BioNTech and Moderna mRNA vaccines, which were approved by the U.S. Food and Drug Administration (FDA) under Emergency Use Authorization (EUA) in late 2020, remai...
Community Health Centers (CHCs) serve over 29 million vulnerable patients, making the lack of data on COVID-19-related racial disparities in patients served in CHCs a critical knowledge gap in assessments of the pandemic's national impact. In rural and poor urban areas, CHCs may be the only accessible healthcare option. Even when other options exist, CHCs reduce barriers such as cost, lack of insu...
HCCI's President and CEO Niall Brennan was featured in a Wall Street Journal Article on hospital price transparency disclosures at Sutter Health. From the article: "'It is shining a light on the insanity of U.S. healthcare pricing,' said Niall Brennan, chief executive of the Health Care Cost Institute, a nonprofit that analyzes medical costs. 'It's at the center of the affordability cri...
New dataset is 25% larger than original HCCI dataset, containing health insurance claims for 55 million people, one third of people with employer-based health insurance in the United States WASHINGTON, DC (February 2, 2021) — The Health Care Cost Institute (HCCI) today announced the launch of its new health care claims dataset for research. The new dataset is more than 25% larger than the original...
Increasingly, policymakers are considering proposals that tie payments made by private health insurers, in some way, to rates paid by Medicare. These proposals are inspired by the rising cost of health care and widespread variation in health care prices. For example, we recently found that the cost of the same service can vary by 5-fold, 10-fold or more within the same market among the commerciall...
